HomeNATCOPHARM • NSE
add
Natco Pharma Ltd
Nakaraang pagsara
₹1,000.80
Sakop ng araw
₹1,000.00 - ₹1,024.90
Sakop ng taon
₹726.80 - ₹1,059.00
Market cap
182.65B INR
Average na Volume
2.12M
P/E ratio
11.73
Dividend yield
0.49%
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 6.47B | 36.33% |
Gastos sa pagpapatakbo | 4.02B | 0.37% |
Net na kita | 1.52B | 13.91% |
Net profit margin | 23.40 | -16.46% |
Kita sa bawat share | 8.46 | 13.86% |
EBITDA | 1.57B | 326.63% |
Aktuwal na % ng binabayarang buwis | 12.03% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 32.04B | 30.08% |
Kabuuang asset | — | — |
Kabuuang sagutin | — | — |
Kabuuang equity | 86.54B | — |
Natitirang share | 179.08M | — |
Presyo para makapag-book | 2.07 | — |
Return on assets | — | — |
Return on capital | 3.15% | — |
Cash Flow
Net change in cash
| (INR) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 1.52B | 13.91% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
Itinatag
1981
Headquarters
Website
Mga Empleyado
4,199
